Atlas Trials

A Trial Using ARV-471 or Anastrozole in Post-Menopausal Women With Breast Cancer Prior to Surgery

Clinical trial NCT05549505 · COMPLETED

Trial details

NCT number
NCT05549505
Sponsor
Arvinas Inc.
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
Breast Cancer
Start date
2023-02-15
Primary completion
2024-07-13
Enrollment
152

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.